Curanex Pharmaceuticals Inc Common Stock (CURX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.5x

Market Cap

$7.86M

MomentumView details →

1D Return

+5.70%

YTD Return

+1462.31%

RSI (14)

82.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.5x

Market Cap

$7.86M

RSI (14)

82.1

MomentumView details →

1D Return

+5.70%

YTD Return

+1462.31%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−218.65%

ROA (TTM)

−206.32%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.03

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

45.95x

Quick Ratio

45.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−10.47M

Op. CF (TTM)

−12.08M

Latest newsMore news →

No recent news for CURX.

Similar companies

Acurx Pharmaceuticals, Inc.ACXP Medicus Pharma Ltd.MDCXW ZyVersa Therapeutics, Inc.ZVSA AlphaTON Capital Corp.ALP Skye Bioscience, Inc.SKYE Bolt Biotherapeutics, Inc.BOLT Find similar companies →

Latest newsMore news →

No recent news for CURX.